SCHEMBL454818

SCHEMBL454818

CCC/C=C/CCCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.67
TRPV1 Q8NER1 1/20 0.67
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
TOP1 P11387 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837920 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL454819 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL514736 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854348 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854970 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2357077 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855889 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855886 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL20584432 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5853539 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US claimed
EP-4711375-A1 METALLOCENE COMPOUND, CATALYST COMPOSITION, OLEFIN POLYMERIZATION METHOD, AND ETHYLENE-CYCLOOLEFIN COPOLYMER AND PREPARATION METHOD THEREFOR China Petroleum & Chemical Corporation (CN) 2026-03-18 EP claimed
EP-4711376-A1 METALLOCENE COMPOUND, CATALYST COMPOSITION ,AND METHOD FOR PREPARING ETHYLENE-CYCLIC OLEFIN COPOLYMER China Petroleum & Chemical Corporation (CN) 2026-03-18 EP claimed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
CN-119732353-B Disorientation composition containing trans-8-dodecene-2, 3-pentafluoropropionate and application thereof 中国农业科学院草原研究所 2025-05-13 CN claimed
CN-119924313-A Sex attractant for fruit borers and preparation method thereof 云南省农业科学院农业环境资源研究所 2025-05-06 CN claimed
CN-119732353-A Disorientation composition containing trans-8-dodecene-2, 3-pentafluoropropionate and application thereof 中国农业科学院草原研究所 2025-04-01 CN claimed
WO-2025035632-A1 METALLOCENE COMPOUND, CATALYST COMPOSITION ,AND METHOD FOR PREPARING ETHYLENE-CYCLIC OLEFIN COPOLYMER 中国石油化工股份有限公司 2025-02-20 WO claimed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO claimed
WO-2024073678-A2 PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE OMEGA THERAPEUTICS, INC. (US) 2024-04-04 WO claimed
US-20110207637-A1 Vicinally Disubstituted Internal Olefins as Constituents of Olefin Copolymers for Lubricating Oil Rheology Modifiers EXXONMOBIL CHEMICAL PATENTS INC. 2011-08-25 US claimed
US-7666966-B2 Method of manufacturing thermoplastic resin, crosslinked resin, and crosslinked resin composite material ZEON CORPORATION (JP) 2010-02-23 US claimed
US-20090275719-A1 Film Comprising Norbornene Compound Addition Polymer ZEON CORPORATION (JP) 2009-11-05 US claimed
US-7037989-B2 Copolymers of ethylene and/or α-olefins and vicinally disubstituted olefins EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-05-02 US claimed
WO-2004106394-A1 COPOLYMERS OF ETHYLENE AND/OR α-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-12-09 WO claimed
US-20040242814-A1 COPOLYMERS OF ETHYLENE AND/OR ALPHA-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS EXXONMOBIL CHEMICAL PATENTS INC. 2004-12-02 US claimed
EP-0161112-B1 NOVEL SUBSTITUTED AROMATIC HYDROCARBONS, PROCESSES FOR PRODUCTION THEREOF, AND USE THEREOF MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-07-25 EP claimed
EP-0161112-A2 Novel substituted aromatic hydrocarbons, processes for production thereof, and use thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1985-11-13 EP claimed
US-4262156-A NEUTRAL METAL CARBENE CATALYST, HALOGENATED AND TIN PROMOTERS PHILLIPS PETROLEUM CO. (US) 1981-04-14 US claimed
US-4180524-A CATALYST OF URANIUM, MOLYBDENUM RHENIUM OR TUNGSTEN COMPOSITE PHILLIPS PETROLEUM COMPANY (US) 1979-12-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS NSUN3, NSUN2, LDLR FAAH 3270/4885TRPV1 3541/4885TERT 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.